Skip to main content
. 2015 Nov;7(11):1927–1938. doi: 10.3978/j.issn.2072-1439.2015.11.43

Table 4. Summary of previous studies on the incidence of CTEPH after acute PE.

First author, year Population Patients (n) Inclusion criteria Exclusion criteria Screening patients for CTEPH by TTE Diagnostic method for CTEPH Median follow-up (months) Incidence of CTEPH (%)
Pengo, 2004 (5) Italy 223 First episode of PE Other diseases that could cause PH, pre-existing exertional dyspnea Patients with dyspnea RHC, PA 94.3 3.8
Becattini, 2006 (6) Italy 259 First episode of PE Persistent risk factors
for VTE
Patients with dyspnea (n=37) RHC, PA 46 0.8
Miniati, 2006 (7) Italy 320 PE Persistence of large bilateral perfusion defects in V/Q scan RHC, PA 25.2 1.3
Klok, 2010 (9) Netherlands 866 PE n=402 RHC, V/Q scan 36 0.57
Poli, 2010 (11) Italy 239 First episode of PE Active cancer; diseases that could cause PH n=223 RHC, V/Q scan 36 0.4
Guérin, 2014 (13) France 146 PE Previously known CTEPH or PH, diseases that could have caused non-thromboembolic PH n=146 RHC, V/Q scan 26 4.8
Otero, 2011 (10) Spain 744 PE Age <18 years Patients with dyspnea (n=121) SPAP >50 mmHg 14 1.3
Dentali, 2009 (8) Italy 91 First episode of PE Other diseases that could cause PH; age <18 years n=91 SPAP ≥40 mmHg, V/Q scan 6-12 8.8
Korkmaz, 2012 (12) Turkey 259 First episode of PE Diseases that could
cause PH
Patients with dyspnea (n=102) SPAP >35 mmHg, V/Q scan 16.3 4.6

Abbreviations: CTEPH, chronic thromboembolic pulmonary hypertension; PA, pulmonary angiography; PE, pulmonary embolism; PH, pulmonary hypertension; RHC, right heart catheterization; SPAP, systolic pulmonary artery pressure; TTE, transthoracic echocardiography; V/Q, ventilation/perfusion; VTE, venous thromboembolism.